370 related articles for article (PubMed ID: 23988294)
1. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
Rudenko L; Isakova-Sivak I; Donina S
Vaccine; 2013 Oct; 31(42):4702-5. PubMed ID: 23988294
[TBL] [Abstract][Full Text] [Related]
2. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
Rudenko L; Isakova-Sivak I; Rekstin A
Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
[TBL] [Abstract][Full Text] [Related]
3. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.
Carter DM; Bloom CE; Kirchenbaum GA; Tsvetnitsky V; Isakova-Sivak I; Rudenko L; Ross TM
Vaccine; 2015 Jan; 33(1):108-16. PubMed ID: 25448100
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
[TBL] [Abstract][Full Text] [Related]
6. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
9. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
10. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L; Kiseleva I; Naykhin AN; Erofeeva M; Stukova M; Donina S; Petukhova G; Pisareva M; Krivitskaya V; Grudinin M; Buzitskaya Z; Isakova-Sivak I; Kuznetsova S; Larionova N; Desheva J; Dubrovina I; Nikiforova A; Victor JC; Neuzil K; Flores J; Tsvetnitsky V; Kiselev O
PLoS One; 2014; 9(2):e87962. PubMed ID: 24533064
[TBL] [Abstract][Full Text] [Related]
11. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
13. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.
Overton ET; Goepfert PA; Cunningham P; Carter WA; Horvath J; Young D; Strayer DR
Vaccine; 2014 Sep; 32(42):5490-5. PubMed ID: 25128802
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses.
Guo L; Wang D; Zhou H; Wu C; Gao X; Xiao Y; Ren L; Paranhos-Baccalà G; Shu Y; Jin Q; Wang J
Sci Rep; 2016 Feb; 6():22045. PubMed ID: 26907865
[TBL] [Abstract][Full Text] [Related]
15. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.
De Groot AS; Moise L; Liu R; Gutierrez AH; Terry F; Koita OA; Ross TM; Martin W
Hum Vaccin Immunother; 2014; 10(2):256-62. PubMed ID: 24525618
[TBL] [Abstract][Full Text] [Related]
16. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
Gravel C; Elmgren C; Muralidharan A; Hashem AM; Jaentschke B; Xu K; Widdison J; Arnold K; Farnsworth A; Rinfret A; Van Domselaar G; Wang J; Li C; Li X
Vaccine; 2015 Feb; 33(9):1129-34. PubMed ID: 25620245
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.
Jiang WM; Wang SC; Liu HL; Yu JM; Du X; Hou GY; Li JP; Liu S; Wang KC; Zhuang QY; Liu XM; Chen JM
Vaccine; 2014 Nov; 32(48):6433-9. PubMed ID: 25285880
[TBL] [Abstract][Full Text] [Related]
19. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
Liu Q; Mena I; Ma J; Bawa B; Krammer F; Lyoo YS; Lang Y; Morozov I; Mahardika GN; Ma W; García-Sastre A; Richt JA
J Virol; 2015 Jul; 89(14):7401-8. PubMed ID: 25926639
[TBL] [Abstract][Full Text] [Related]
20. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
